Thrombopoietin is associated with δ's intercept, and only in Non-Hispanic Whites

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

Volumn 3, Issue , 2016, Pages 35-42

  Royall, Donald R ^a,b,c   Palmer, Raymond F ^b  

^a University of Texas Health Science Center   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Aging; Cognition; Dementia; Functional status; Intelligence; THPO

Indexed keywords

THROMBOPOIETIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; CLINICAL DEMENTIA RATING; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICAN AMERICAN; MILD COGNITIVE IMPAIRMENT;

EID: 84961627267     PISSN: None     EISSN: 23528729     Source Type: Journal    
DOI: 10.1016/j.dadm.2016.02.003     Document Type: Article

References (36)

1. Royall D.R., Palmer R.F., O'Bryant S.E. Validation of a latent variable representing the dementing process. J Alzheimers Dis 2012, 30:639-649.
2. Royall D.R. Welcome back to your future: The psychometric assessment of dementia by the latent variable "δ". J Alzheimers Dis 2016, 49:515-519.
3. Royall D.R., Palmer R.F., Matsuoka T., Kato Y., Taniguchi S., Ogawa M., et al. Greater than the sum of its parts: δ can be constructed from item-level data. J Alzheimers Dis 2016, 49:571-579.
4. Gavett B.E., John S.E., Gurnani A.S., Bussell C.A., Saurman J.L. The role of Alzheimer's and cerebrovascular pathology in mediating the effects of age, race, and apolipoprotein E genotype on dementia severity in pathologically confirmed Alzheimer's disease. J Alzheimers Dis 2016, 49:531-545.
5. Koppara A., Wolfsgruber S., Kleineidam L., Schmidtke K., Frölich L., Kurz A., et al. The latent dementia phenotype δ is associated with CSF biomarkers of Alzheimer Disease and predicts conversion to AD dementia in subjects with MCI. J Alzheimers Dis 2016, 49:547-560.
6. Royall D.R., Palmer R.F. Ethnicity moderates dementia's biomarkers. J Alzheimers Dis 2015, 43:275-287.
7. Gavett B.E., Vudy V., Jeffrey M., John S.E., Gurnani A.S., Adams J.W. The δ latent dementia phenotype in the uniform data set: cross-validation and extension. Neuropsychology 2015, 29:344-352.
8. Palmer R.F., Royall D.R. Future dementia severity is almost entirely explained by the latent variable δ's intercept and slope. J Alzheimers Dis 2016, 49:521-529.
9. O'Bryant S.E., Xiao G., Barber R., Huebinger R., Wilhelmsen K., Edwards M., et al. A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI. PLoS One 2011, 6:e28092. Texas Alzheimer's Research & Care Consortium, Alzheimer's Disease Neuroimaging InitiativeAlzheimer's Disease Neuroimaging Initiative.
10. O'Bryant S.E., Xiao G., Zhang F., Edwards M., German D.C., Yin X., et al. Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues. J Alzheimers Dis 2014, 42:1325-1335.
11. O'Bryant S.E., Xiao G., Edwards M., Devous M., Gupta V.B., Martins R., et al. Biomarkers of Alzheimer's Disease among Mexican Americans. J Alzheimers Dis 2013, 34:841-849.
12. Kissel K., Berber S., Nockher A., Santoso S., Bein G., Hackstein H. Human platelets target dendritic cell differentiation and production of proinflammatory cytokines. Transfusion 2006, 46:818-827.
13. Wechsler D. Wechsler Memory Scale 1997, The Psychological Corporation, San Antonio, TX. 3rd ed.
14. Benton A., Hamsher K. Multilingual Aphasia Examination 1989, AJA Associates, Iowa City, Iowa.
15. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969, 9:179-186.
16. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. A new clinical scale for the staging of dementia. Br J Psychiatry 1982, 140:566-572.
17. Waring S., O'Bryant S.E., Reisch J.S., Diaz-Arrastia R., Knebl J., Doody R. The Texas Alzheimer's Research Consortium longitudinal research cohort: Study design and baseline characteristics. Texas Public Health Journal 2008, 60:9-13. for the Texas Alzheimer's Research Consortium.
18. Stine R.A. Graphical interpretation of variance inflation factors. Am Stat 1995, 49:53-56.
19. Mardia KV. Tests of univariate and multivariate normality. In Krishnaiah PR, ed. Handbook of Statistics, Volume 1; 1980. p. 279-320. Chapter 9, North-Holland, Amsterdam.
20. Arbuckle J.L. AMOS 18 User's Guide 2006, SPSS, Chicago.
21. Grice J.W. Computing and evaluation factor scores. Psychol Methods 2001, 6:430-450.
22. Graham J.W. Missing data analysis: Making it work in the real world. Annu Rev Psychol 2009, 6:549-576.
23. Enders C.K., Bandalos D.L. The relative performance of full information maximum likelihood estimation for missing data in structural equation models. Struct Equ Modeling 2001, 8:430-457.
24. Newman D.A. Missing data techniques and low response rates: The role of systematic nonresponse parameters. Statistical and methodological myths and urban legends: Doctrine, verity and fable in the organizational and social sciences 2009, 7-36. Routledge/Taylor & Francis Group, New York, NY, US, xix. C.E. Lance, R.J. Vandenberg (Eds.).
25. PASW Statistics 18, Release Version 18.0.0 2009, SPSS, Inc, Chicago, IL.
26. Guttman L. The determinancy of factor score matrices with applications for five other problems of common factor theory. Br J Stat Psychol 1955, 8:65-82.
27. Bollen K.A., Long J.S. Testing structural equation models 1993, Sage Publications, Thousand Oaks, CA.
28. Wheaton B., Muthén B., Alwin D.F., Summer G.F. Assessing reliability and stability in panel models. Sociology Methodology 1977, Jossey-Bass, San Francisco, CA. D.R. Heise (Ed.).
29. Bentler P.M. Comparative fit indexes in structural models. Psychol Bull 1990, 107:238-246.
30. Browne M., Cudeck R. Alternative ways of assessing model fit. Testing structural equation models 1993, 136-162. Sage Publications, Thousand Oaks, CA. K.A. Bollen, J.S. Long (Eds.).
31. Zweig M.H., Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993, 39:561-577.
32. Mapstone M., Cheema A.K., Fiandaca M.S., Zhong X., Mhyre T.R., MacArthur L.H., et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 2014, 20:415-418.
33. Reiff R.E., Ali B.R., Baron B., Yu T.W., Ben-Salem S., Coulter M.E., et al. METTL23, a transcriptional partner of GABPA, is essential for human cognition. Hum Mol Genet 2014, 23:3456-3466.
34. Witte M.M., Trzepacz P., Case M., Yu P., Hochstetler H., Quinlivan M., et al. Association between clinical measures and Florbetapir F18 PET neuroimaging in mild or moderate Alzheimer's disease dementia. J Neuropsychiatry Clin Neurosci 2014, 26:214-220.
35. Kwon O.D., Khaleeq A., Chan W., Pavlik V.N., Doody R.S. Apolipoprotein E polymorphism and age at onset of Alzheimer's disease in a quadriethnic sample. Dement Geriatr Cogn Disord 2010, 30:486-491.
36. Janicki S.C., Park N., Cheng R., Clark L.N., Lee J.H., Schupf N. Estrogen receptor α variants affect age at onset of Alzheimer's disease in a multiethnic female cohort. Dement Geriatr Cogn Disord 2014, 38:200-213.